• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients

by MM360 Staff | Sep 3, 2025 | Publications

ESMO Open. 2025 Aug;10(8):105514. doi: 10.1016/j.esmoop.2025.105514. Epub 2025 Jul 15. ABSTRACT BACKGROUND: The treatment landscape for relapsed/refractory multiple myeloma (RRMM) is rapidly evolving, particularly for patients exposed or refractory to lenalidomide....

Safety and efficacy of BCMA CAR-T vs. bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysis

by MM360 Staff | Aug 19, 2025 | Publications

Haematologica. 2025 Aug 14. doi: 10.3324/haematol.2025.288174. Online ahead of print. ABSTRACT Not available. PMID:40820831 | DOI:10.3324/haematol.2025.288174

Symptomatic progression-free survival as an emerging patient-centered endpoint in multiple myeloma: a secondary analysis of MagnetsiMM-3 trial data

by MM360 Staff | Aug 10, 2025 | Publications

BMC Cancer. 2025 Aug 8;25(1):1288. doi: 10.1186/s12885-025-14724-6. ABSTRACT BACKGROUND: There is a need to better reflect the patient experience in multiple myeloma (MM), beyond just clinical progression, with the use of a novel endpoint that combines disease...

Value of Spectral CT Techniques for the Assessment of Bone Marrow Infiltration in Multiple Myeloma: A Systematic Literature Review

by MM360 Staff | Jul 25, 2025 | Publications

Rofo. 2025 Jul 23. doi: 10.1055/a-2625-5643. Online ahead of print. ABSTRACT Multiple myeloma (MM) is the second most common hemato-oncological malignancy, characterized by the clonal proliferation of malignant plasma cells and bone marrow infiltration. The degree of...

Treatment-related cognitive changes in multiple myeloma: A systematic review and meta-analysis

by MM360 Staff | Jul 22, 2025 | Publications

J Geriatr Oncol. 2025 Jul 19;16(7):102321. doi: 10.1016/j.jgo.2025.102321. Online ahead of print. ABSTRACT INTRODUCTION: Multiple myeloma (MM) is an incurable blood cancer with improved survival rates due to advances in treatment, including stem cell transplantation,...

Spinal intradural lesion as manifestation of multiple myeloma: Illustrative case and systematic review of literature

by MM360 Staff | Jul 15, 2025 | Publications

Surg Neurol Int. 2025 Jun 20;16:247. doi: 10.25259/SNI_249_2025. eCollection 2025. ABSTRACT BACKGROUND: Multiple myeloma (MM) typically affects the bone marrow. When it spreads to the central nervous system, it usually presents as intracranial metastasis or extradural...
« Older Entries

Recent Content

  • A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
  • Subcutaneous Bortezomib Associated With Reduced Incidence of Peripheral Neuropathy in Multiple Myeloma
  • Multiple Myeloma: Key Insights on Diagnosis and Evolving Treatment Strategies
  • Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation
  • Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
  • Incidence and prevalence of clinically detected smoldering multiple myeloma within the general population: a retrospective observational cohort study
  • The long non-coding RNA CRNDE stabilises SIRT1 protein and influences Hedgehog signalling in multiple myeloma
  • What Does Multiple Myeloma Mean?
  • FDA Update: Darzalex Faspro Not Approved for Multiple Myeloma
  • Temporal genomic dynamics shape clinical trajectory in multiple myeloma
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT